Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition

L.E.M. Willemsen; J.P. Hoetjes; S.J.H. van Deventer; E.A. van Tol

Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition

L.E.M. Willemsen, J.P. Hoetjes, S.J.H. van Deventer, E.A. van Tol

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	275-284
Number of pages	9
Journal	Clinical and Experimental Immunology
Volume	142
Publication status	Published - 2005

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Farmacie(FARM)
Biomedische technologie en medicijnen
Immunology
Pharmacology
Overig medisch onderzoek

Cite this

@article{9b844219d8b34c6481385d3cf8bdca69,

title = "Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Farmacie(FARM), Biomedische technologie en medicijnen, Immunology, Pharmacology, Overig medisch onderzoek",

author = "L.E.M. Willemsen and J.P. Hoetjes and {van Deventer}, S.J.H. and {van Tol}, E.A.",

year = "2005",

language = "Undefined/Unknown",

volume = "142",

pages = "275--284",

journal = "Clinical and Experimental Immunology",

issn = "0009-9104",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition

AU - Willemsen, L.E.M.

AU - Hoetjes, J.P.

AU - van Deventer, S.J.H.

AU - van Tol, E.A.

PY - 2005

Y1 - 2005

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Immunology

KW - Pharmacology

KW - Overig medisch onderzoek

M3 - Article

SN - 0009-9104

VL - 142

SP - 275

EP - 284

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

ER -